Aug 29, 2023 | Covid-19, News
The US Centers for Disease Control and Prevention (CDC) issued its initial risk assessment of the BA.2.86 SARS-CoV-2 lineage, which says tests and treatments will likely be effective and that updated vaccines will still be able to reduce severe disease and... 
Aug 22, 2023 | Covid-19, News
In one of the largest studies of its kind, researchers provide answers to whether COVID-19 vaccinations reduce sickness and mortality following infection with SARS-CoV-2. The study published in The Lancet Microbe found among individuals recently infected with... 
Aug 22, 2023 | Covid-19, News
Colorized scanning electron micrograph of a cell infected with a variant strain of SARS-CoV-2 virus particles (green), isolated from a patient sample. CREDIT: NIAID/NIH Severe COVID-19 may cause long-lasting alterations to the innate immune system, the first line of... 
Aug 9, 2023 | Covid-19, News
CREDIT: NIH/NIAID cc A fourth dose of the bivalent (two-strain) COVID-19 vaccine is substantially more effective against medical treatment and hospitalization than a fourth monovalent (single-strain) dose among both previously infected and never-infected people who... 
Aug 2, 2023 | Covid-19, News
By Maria Fernanda Ziegler | Agência FAPESP – Researchers at the University of São Paulo (USP) in Brazil have identified a new class of molecules capable of stopping the excessive inflammation typical of the severe form of COVID-19 without impairing the immune... 
Jul 26, 2023 | Covid-19, Infection Control, News
Member States of the World Health Organization (WHO) continued their discussions toward a global accord on pandemic prevention, preparedness, and response, with a view to presenting the outcome of their work to the World Health Assembly in May 2024. The Bureau’s text...
